Search research articles
Contact Us
Filters
Showing results (221-230 of 319) with videos related to
Page
of 32
Sort By:
The New England Journal of Medicine
|
May 30, 2003
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
Adriano Lazzarin, Bonaventura Clotet, David Cooper, et al.
Open Forum Infectious Diseases
|
January 30, 2020
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel <i>Staphylococcus aureus</i> 4-Antigen Vaccine (SA4Ag)
C Buddy Creech, Robert W Frenck, Anne Fiquet, et al.
Vaccine
|
July 9, 2022
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A
Li Hao, Michelle M Kuttel, Neil Ravenscroft, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2021
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie, Yang Liu, Jianying Liu, et al.
The Journal of Infectious Diseases
|
December 21, 2021
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine
Ann R Falsey, Edward E Walsh, Daniel A Scott, et al.
Nature
|
June 10, 2021
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Jianying Liu, Yang Liu, Hongjie Xia, et al.
Nature Medicine
|
February 9, 2021
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie, Yang Liu, Jianying Liu, et al.
The Journal of Infectious Diseases
|
October 12, 2021
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine
James T Peterson, Agnieszka M Zareba, David Fitz-Patrick, et al.
The Journal of Infectious Diseases
|
December 21, 2021
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine
Edward E Walsh, Ann R Falsey, Daniel A Scott, et al.
NPJ Vaccines
|
April 9, 2022
BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants
Jianying Liu, Yang Liu, Hongjie Xia, et al.
Page
of 32
Search research articles
Search
Showing results (221-230 of 319) with videos related to
Sort By:
Page
of 32
The New England Journal of Medicine
|
May 30, 2003
Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia
Adriano Lazzarin, Bonaventura Clotet, David Cooper, et al.
Open Forum Infectious Diseases
|
January 30, 2020
Persistence of Immune Responses Through 36 Months in Healthy Adults After Vaccination With a Novel <i>Staphylococcus aureus</i> 4-Antigen Vaccine (SA4Ag)
C Buddy Creech, Robert W Frenck, Anne Fiquet, et al.
Vaccine
|
July 9, 2022
Streptococcus pneumoniae serotype 15B polysaccharide conjugate elicits a cross-functional immune response against serotype 15C but not 15A
Li Hao, Michelle M Kuttel, Neil Ravenscroft, et al.
Biorxiv : the Preprint Server for Biology
|
February 3, 2021
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie, Yang Liu, Jianying Liu, et al.
The Journal of Infectious Diseases
|
December 21, 2021
Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine
Ann R Falsey, Edward E Walsh, Daniel A Scott, et al.
Nature
|
June 10, 2021
BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants
Jianying Liu, Yang Liu, Hongjie Xia, et al.
Nature Medicine
|
February 9, 2021
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera
Xuping Xie, Yang Liu, Jianying Liu, et al.
The Journal of Infectious Diseases
|
October 12, 2021
Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine
James T Peterson, Agnieszka M Zareba, David Fitz-Patrick, et al.
The Journal of Infectious Diseases
|
December 21, 2021
A Randomized Phase 1/2 Study of a Respiratory Syncytial Virus Prefusion F Vaccine
Edward E Walsh, Ann R Falsey, Daniel A Scott, et al.
NPJ Vaccines
|
April 9, 2022
BNT162b2-elicited neutralization of Delta plus, Lambda, Mu, B.1.1.519, and Theta SARS-CoV-2 variants
Jianying Liu, Yang Liu, Hongjie Xia, et al.
Page
of 32